Contemporary Management of 1–4 Brain Metastases

by Sarah M. C. Sittenfeld, John H. Suh, Erin S. Murphy, Jennifer S. Yu, Samuel T. Chao
Published 2018-09-01

Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases

by Adam Lauko, Rupesh Kotecha, Addison Barnett, Hong Li, Vineeth Tatineni, Assad Ali, Pradnya Patil, Alireza M. Mohammadi, Samuel T. Chao, Erin S. Murphy, Lilyana Angelov, John H. Suh, Gene H. Barnett, Nathan A. Pennell, Manmeet S. Ahluwalia
Published 2021-09-01

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases

by Tyler Gutschenritter, Vyshak A. Venur, Stephanie E. Combs, Balamurugan Vellayappan, Anoop P. Patel, Matthew Foote, Kristin J. Redmond, Tony J. C. Wang, Arjun Sahgal, Samuel T. Chao, John H. Suh, Eric L. Chang, Richard G. Ellenbogen, Simon S. Lo
Published 2021-12-01

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704

by William F. Regine, MD, Kathryn Winter, MS, Ross A. Abrams, MD, Howard Safran, MD, Ivan L. Kessel, MD, Yuhchyau Chen, MD, PhD, James A. Fugazzi, MD, Eric D. Donnelly, MD, Thomas A. DiPetrillo, MD, Samir Narayan, MD, John P. Plastaras, MD, Rakesh Gaur, MD, Guila Delouya, MD, John H. Suh, MD, Joshua E. Meyer, MD, Michael G. Haddock, MD, Mukund S. Didolkar, MD, Gilbert D.A. Padula, MD, David Johnson, MD, John P. Hoffman, MD, Christopher H. Crane, MD
Published 2018-04-01